Effect of nifedipine on exercise tolerance in patients with angina pectoris
- PMID: 786677
- DOI: 10.1007/BF00561561
Effect of nifedipine on exercise tolerance in patients with angina pectoris
Abstract
To test if nifedipine, 10 mg sublingually, could increase exercise tolerance, ten patients with angina pectoris each performed two types of bicycle exercise test, one with a stepwise increase in load and the other with a continuously increasing load. The drug was given in a double-blind cross-over trial. Nifedipine raised the heart rate and diminished the systemic blood pressure at rest, on standing and during exercise at comparable loads. Work time was prolonged and higher work loads were achieved. The total work performed rose by 50 per cent in one of the tests and by 23 per cent in the other, about 50 minutes after taking the drug. The mechanism of the greater work capacity in angina pectoris after nifedipine was assumed to be diminished heart work due to a fall in systemic vascular resistance.
Similar articles
-
Effect of a calcium inhibitor, nifedipine, on exercise tolerance in patients with angina pectoris: a double-blind study.Chest. 1981 Mar;79(3):302-5. doi: 10.1378/chest.79.3.302. Chest. 1981. PMID: 7009084 Clinical Trial.
-
Antianginal efficiency of nifedipine with and without a beta-blocker, studied with exercise test. A double-blind, randomized subacute study.Clin Cardiol. 1979 Jun;2(3):203-11. doi: 10.1002/clc.4960020306. Clin Cardiol. 1979. PMID: 389513 Clinical Trial.
-
Effects of felodipine versus nifedipine on exercise tolerance in stable angina pectoris.Am J Cardiol. 1994 Apr 1;73(9):658-60. doi: 10.1016/0002-9149(94)90929-6. Am J Cardiol. 1994. PMID: 8166061 Clinical Trial.
-
Efficacy, duration and mechanism of action of nifedipine in stable exercise-induced angina pectoris.Eur Heart J. 1983 Dec;4(12):873-81. doi: 10.1093/oxfordjournals.eurheartj.a061415. Eur Heart J. 1983. PMID: 6363078 Clinical Trial.
-
Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The Zatebradine Study Group.J Am Coll Cardiol. 1995 Aug;26(2):305-12. doi: 10.1016/0735-1097(95)80000-7. J Am Coll Cardiol. 1995. PMID: 7608428 Clinical Trial.
Cited by
-
An exercise hemodynamic comparison of verapamil, diltiazem, and amlodipine in coronary artery disease.Cardiovasc Drugs Ther. 1990 Apr;4(2):457-63. doi: 10.1007/BF01857754. Cardiovasc Drugs Ther. 1990. PMID: 2149514 Clinical Trial.
-
Acute and chronic effects of nifedipine in arterial hypertension.Eur J Clin Pharmacol. 1978 Dec 18;14(6):375-81. doi: 10.1007/BF00716377. Eur J Clin Pharmacol. 1978. PMID: 738346 No abstract available.
-
Haemodynamic dose-response effects of intravenous nisoldipine in coronary artery disease.Br J Clin Pharmacol. 1985 Dec;20(6):675-80. doi: 10.1111/j.1365-2125.1985.tb05127.x. Br J Clin Pharmacol. 1985. PMID: 4091998 Free PMC article.
-
Hemodynamic interactions of a new beta blocker, celiprolol, with nifedipine in angina pectoris.Cardiovasc Drugs Ther. 1991 Aug;5(4):681-7. doi: 10.1007/BF03029741. Cardiovasc Drugs Ther. 1991. PMID: 1679661 Clinical Trial.
-
Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.Cardiovasc Drugs Ther. 1988 Jan;1(5):461-91. doi: 10.1007/BF02125731. Cardiovasc Drugs Ther. 1988. PMID: 3154677 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources